The University of Connecticut is one of the top public research universities in USA. Postdoctoral and Visiting Scholar positions are available in Dr. Laijun Lai’s laboratory. The research projects include: 1) enhancing antitumor immunity by recombinant proteins or antibodies (EMBO Mol Med. 13(5):e13404, 2021; Cellular & Molecular Immunology, 18(8): 1920-1933, 2021; Am J Cancer Res. 7:1714-1723, 2017; Molecular Cancer Therapeutics, 15(10):2413-2421, 2016; Cancer Research. 71:61-67, 2011), 2) preventing and treating immunodeficiency and autoimmune diseases by proteins, embryonic stem cells or induced pluripotent stem cells (iPSCs)-derived cells (Rheumatology. 61(3):1255-1264, 2022; J Neuroinflammation. 2021 Nov 13;18(1):268; J Immunol. 203:400, 2020; Front Immunol. 11:1781, 2020; J Immunol. 203:400-407, 2019; Stem Cell Res Ther. 10:239, 2019; Adv Healthc Mater. 8(9):e1800987, 2019; Frontiers in Immunology.9:2657, 2018; Stem Cells Transl Med. 6:121-130, 2017; Cell Immunol. 322:84-91, 2017; Br J Haematol. 175:505-516, 2016; Scientific Reports. 5: 9882, 2015; J Autoimmun. 58:36-47, 2015; Stem cells and Development. 23:1491-500, 2014; Journal of Clinical Investigation. 122:3552, 2012; Blood. 118:3410, 2011; Stem cells. 27:3012, 2009); and 3) improving T cell regeneration after bone marrow transplantation (Cell Immunol. 335:22-29, 2019; Immunology. 144:245-253, 2015; Plos ONE 8(12): e82998, 2013; Journal of Immunology, 186: 1915, 2011; Transplantation. 92:516, 2011). Candidates should have PhD, MD/PhD, or MD. A strong background in Cellular & Molecular Biology and previous research experience or training in immunology, stem cells, or cancer, and mouse models is preferred. If interested, please send your cover letter and CV to: [email protected]